AlphaStocks
4.3
Weak

Encompass Health Corp (EHC)

Health Care / Health Care Facilities

S&P MidCap 400

$97.45

Below average on several measures. Research carefully.

Weak

Score based on 4 of 5 models — moderate confidence

#766out of 1127 in Health Care

Is Encompass Health Corp a Good Investment in 2026?

Encompass Health Corp (EHC) scores 4.3 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Buffett model rates Encompass Health Corp as Attractive. However, the Lynch model rates it Caution — High PEG — growth premium · Slow Grower. Encompass Health Corp currently trades below its estimated fair value of $142, suggesting potential upside. Encompass Health Corp ranks #766 out of 1127 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E17.6ROE23.5Market Cap10BDiv Yield0.7

Estimated Fair Value

$142.3132% below

Fair value above market price. EPS grew 24% year-over-year. ROE of 24% signals strong profitability. P/E of 18x is moderate for this quality level.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Limited Data

Financial health check (9 signals)

Buffett

Attractive

Business quality & competitive moat

Graham

Caution

79% above fair value

Lynch

Caution

High PEG — growth premium · Slow Grower

Greenblatt

Attractive

Top half (rank 49%)

Frequently Asked Questions

Is Encompass Health Corp (EHC) a good investment?
Based on AlphaStocks' composite analysis, Encompass Health Corp (EHC) scores 4.3 out of 10, earning a Weak rating. This score is below average, suggesting caution. Fair value above market price. EPS grew 24% year-over-year. ROE of 24% signals strong profitability. P/E of 18x is moderate for this quality level.
What is Encompass Health Corp's Piotroski F-Score?
Encompass Health Corp's Piotroski F-Score status is Limited Data. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is EHC overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $142, EHC appears undervalued. The stock currently trades 32% below its estimated fair value. Fair value above market price. EPS grew 24% year-over-year. ROE of 24% signals strong profitability. P/E of 18x is moderate for this quality level.
How does EHC compare to other Health Care stocks?
Encompass Health Corp ranks #766 out of 1127 stocks in the Health Care sector, placing it in the top 68% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about EHC?
AlphaStocks evaluates EHC using five proven investment models. Buffett: Attractive; Graham: Caution; Lynch: Caution; Greenblatt Magic Formula: Attractive. These models are combined into a single composite score of 4.3/10.

Similar Stocks

PARRFTIAZN

Compare EHC with

EHC vs PARREHC vs FTIEHC vs AZN

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer